GA HB783

Revises the definition of "low THC oil" to remove the requirement that cannabidiol content must equal or exceed the tetrahydrocannabinol content, while maintaining the 5% THC weight limit and prohibition on plant material exhibiting Cannabis morphological features

Adds three new substances to Schedule I controlled substances — Methoxyphencyclidine (MeO-PCP), 4-OH-MiPT, and 5-MAPB — and replaces individually named synthetic cannabinoids with broader structural class categories (e.g., indole carboxamides, indazole carboxylates, naphthoylindazoles)

Restructures Schedule IV by removing individually listed benzodiazepines (e.g., alprazolam, clonazepam, diazepam, lorazepam, triazolam) and replacing them with a new structural class definition covering all compounds derived from 1,4-benzodiazepine with specified substitution patterns

Creates a new "restricted dangerous drug" classification for substances with no medical use that cannot be prescribed, manufactured, or possessed, specifically listing Salvinorin A and Salvia divinorum, with an exception for FDA-approved research

Adds over 40 new substances to the dangerous drug list, exempts budesonide nasal spray (up to 32 mcg per spray) from dangerous drug restrictions, and makes knowingly distributing or reselling nonprescription injectable insulin originally obtained over-the-counter a misdemeanor, with such insulin subject to seizure as an adulterated drug